Magdalena Korecka
Papers
1
Total Citations
62
H-Index
1
About
Magdalena Korecka is a leading analytical biochemist whose work has been instrumental in advancing the standardization of Alzheimer’s disease (AD) blood-based biomarkers. Her primary research focuses on the pre-analytical and analytical validation of plasma β-amyloid (Aβ) and tau measurements, addressing a critical bottleneck in the field: the high variability of results across different laboratories and studies. Her most-cited work, an improved protocol for measuring plasma Aβ in the Alzheimer’s Disease Neuroimaging Initiative (ADNI), has garnered 62 citations and directly tackled the interassay inconsistency that hindered cross-study meta-analyses. By establishing rigorous, standardized protocols, Korecka has enabled more reliable longitudinal evaluation of AD biomarkers, paving the way for their potential use in clinical trials and early diagnosis. Her contributions are foundational for the field’s shift toward blood-based diagnostics, ensuring that data from multi-center studies can be compared and combined with confidence. Through her meticulous method development, Korecka has provided the research community with the tools necessary to translate biomarker discovery into reproducible, actionable clinical insights.
Research Focus
Key Achievements
Top Papers
- 1